Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CYFIP1 and PKM2 Synergistically Regulate ROS and Glycolysis in Colorectal Cancer Through the AKT/mTOR/HIF-1α Cascad

NCT07197151 is registered in ClinicalTrials.gov with hui hou as lead sponsor.

NCT NCT07197151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07197151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CYFIP1 and PKM2 Synergistically Regulate ROS and Glycolysis in Colorectal Cancer Through the AKT/mTOR/HIF-1α Cascad
Lead sponsor
hui hou
Phase
Observational
Overall status
Completed
Start date
August 1, 2022
Completion date
September 1, 2025
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer (crc), specimens are to be collected from subjects who are having or have had a fluid or tissue removed, a biopsy or a blood or bone marrow draw